A nurse is caring for a client who has a kidney transplant and is receiving cyclosporine (Sandimmune), a calcineurin inhibitor. What is the primary mechanism of action of cyclosporine in this condition?
A It inhibits the synthesis of inflammatory mediators and suppresses the activation and proliferation of immune cells.
B It blocks the activation of T cells by inhibiting the enzyme calcineurin, which is required for the transcription of interleukin-2.
C It interferes with the synthesis of nucleic acids, which are essential for the replication and function of immune cells.
D It binds to specific antigens or receptors on the surface of immune cells and either neutralizes them or induces their destruction.
The Correct Answer and Explanation is:
The correct answer is B: It blocks the activation of T cells by inhibiting the enzyme calcineurin, which is required for the transcription of interleukin-2.
Explanation:
Cyclosporine (Sandimmune) is a critical medication used in the management of organ transplant recipients to prevent rejection. Its primary mechanism of action involves the inhibition of T cell activation, which is crucial for its immunosuppressive effects.
- Mechanism of Action: Cyclosporine specifically targets the enzyme calcineurin. Calcineurin is a protein phosphatase that plays a pivotal role in the activation of T cells. For T cells to become activated, they must produce interleukin-2 (IL-2), a cytokine essential for T cell proliferation and activation. IL-2 is produced when calcineurin dephosphorylates nuclear factor of activated T cells (NFAT), a transcription factor. By inhibiting calcineurin, cyclosporine prevents this dephosphorylation process, thereby blocking the activation of NFAT and the subsequent transcription of IL-2. Without IL-2, T cells cannot proliferate or become fully activated, which is essential for preventing organ rejection.
- Clinical Relevance: By suppressing T cell activation, cyclosporine effectively reduces the immune system’s ability to attack the transplanted organ, thereby preventing acute rejection. This targeted approach helps manage the immune response without broadly suppressing the entire immune system, which is beneficial in minimizing the risk of infections and other complications associated with general immunosuppression.
- Comparison with Other Options:
- Option A: This describes a general mechanism of immunosuppressants but does not specifically apply to cyclosporine. Cyclosporine’s action is more precisely targeted.
- Option C: This option refers to a different class of drugs, such as antimetabolites, which interfere with nucleic acid synthesis.
- Option D: This describes mechanisms such as monoclonal antibodies or other immunomodulatory drugs, not cyclosporine.
In summary, cyclosporine’s primary action is the inhibition of calcineurin, thereby blocking T cell activation and the production of IL-2, which is critical for transplant success and rejection prevention.